Clinical trial
Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients
NCT03727399 is registered in ClinicalTrials.gov with Mabylon AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients
- Lead sponsor
- Mabylon AG
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- October 1, 2018
- Completion date
- December 31, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pollen allergy